Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
Prostate cancer is the most common cancer among men worldwide, especially in those over 65, and is a leading cause of cancer-related mortality. The disease typically advances from an androgen-dependent state to castration-resistant prostate cancer (CRPC), which poses significant treatment challenges...
Saved in:
Main Authors: | Caihong Li, Dongkai Cheng, Peng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1542811/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01) -
Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
by: Hua Huang, et al.
Published: (2025-02-01) -
Relationship between androgen receptor and androgen receptor-related protein expression in breast cancers focusing on morphologically identified carcinoma with apocrine differentiation
by: Haruto Nishida, et al.
Published: (2025-01-01) -
Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer?
by: Tryambak Pratap Srivastava, et al.
Published: (2025-01-01) -
SNP rs9364554 Modulates Androgen Receptor Binding and Drug Response in Prostate Cancer
by: Yuqian Yan, et al.
Published: (2025-01-01)